MNTA: didn't you guys get the feeling from listening to the cc that MNTA management believes that they will be the sole generic. They didn't say it but it was on the tip of Wheelers tongue. Wheeler did emphasize the importance of full characterization in the FDA's decision. Teva argues otherwise.
I liked hearing that they don't believe an AG is coming from Sanofi. Good CC!,